Engineering a degradable polyurethane intravaginal ring for sustained delivery of dapivirine

2011 ◽  
Vol 1 (3) ◽  
pp. 223-237 ◽  
Author(s):  
Manpreet Kaur ◽  
Kavita M. Gupta ◽  
Azadeh E. Poursaid ◽  
Prasoona Karra ◽  
Alamelu Mahalingam ◽  
...  
2012 ◽  
Vol 163 (2) ◽  
pp. 240-248 ◽  
Author(s):  
Justin T. Clark ◽  
Todd J. Johnson ◽  
Meredith R. Clark ◽  
Joel S. Nebeker ◽  
Judit Fabian ◽  
...  

2014 ◽  
Vol 103 (11) ◽  
pp. 3611-3620 ◽  
Author(s):  
Manjula Gunawardana ◽  
Marc M. Baum ◽  
Thomas J. Smith ◽  
John A. Moss

2013 ◽  
Vol 57 (8) ◽  
pp. 3994-3997 ◽  
Author(s):  
John A. Moss ◽  
Amanda M. Malone ◽  
Thomas J. Smith ◽  
Sean Kennedy ◽  
Cali Nguyen ◽  
...  

ABSTRACTMultipurpose technologies that simultaneously protect from sexually transmitted infections and unintended pregnancy are urgently needed. Pod-intravaginal rings (IVRs) formulated with the antiretroviral agents (ARVs) tenofovir, nevirapine, and saquinavir and the contraceptives etonogestrel and estradiol were evaluated in sheep. Steady-state concentrations were maintained for 28 days with controlled, sustained delivery. This proof-of-principle study demonstrates that pod IVRs can deliver three ARVs from different mechanistic classes and a progestin-estrogen combination over the wide range needed for putative preventative efficacy.


2015 ◽  
Vol 495 (1) ◽  
pp. 579-587 ◽  
Author(s):  
Marc M. Baum ◽  
Irina Butkyavichene ◽  
Scott A. Churchman ◽  
Gilbert Lopez ◽  
Christine S. Miller ◽  
...  

2012 ◽  
Vol 101 (2) ◽  
pp. 576-587 ◽  
Author(s):  
Meredith R. Clark ◽  
Todd J. Johnson ◽  
R. Tyler Mccabe ◽  
Justin T. Clark ◽  
Anthony Tuitupou ◽  
...  

2009 ◽  
pp. 090624002829090
Author(s):  
Tristan P. Learoyd ◽  
Jane L. Burrows ◽  
Eddie French ◽  
Peter C. Seville

2019 ◽  
Vol 9 (3) ◽  
pp. 248-263 ◽  
Author(s):  
Ashish K. Parashar ◽  
Preeti Patel ◽  
Arun K. Gupta ◽  
Neetesh K. Jain ◽  
Balak Das Kurmi

Background: The present study was aimed at developing and exploring the use of PEGylated Poly (propyleneimine) dendrimers for the delivery of an anti-diabetic drug, insulin. Methods: For this study, 4.0G PPI dendrimer was synthesized by successive Michael addition and exhaustive amidation reactions, using ethylenediamine as the core and acrylonitrile as the propagating agent. Two different activated PEG moieties were employed for PEGylation of PPI dendrimers. Various physicochemical and physiological parameters UV, IR, NMR, TEM, DSC, drug entrapment, drug release, hemolytic toxicity and blood glucose level studies of both PEGylated and non- PEGylated dendritic systems were determined and compared. Results: PEGylation of PPI dendrimers caused increased solubilization of insulin in the dendritic framework as well as in PEG layers, reduced drug release and hemolytic toxicity as well as increased therapeutic efficacy with reduced side effects of insulin. These systems were found to be suitable for sustained delivery of insulin by in vitro and blood glucose-level studies in albino rats, without producing any significant hematological disturbances. Conclusion: Thus, surface modification of PPI dendrimers with PEG molecules has been found to be a suitable approach to utilize it as a safe and effective nano-carrier for drug delivery.


Pharmaceutics ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 605
Author(s):  
Marie-Emérentienne Cagnon ◽  
Silvio Curia ◽  
Juliette Serindoux ◽  
Jean-Manuel Cros ◽  
Feifei Ng ◽  
...  

This article describes the utilization of (methoxy)poly(ethylene glycol)-b-poly(1,3-trimethylene carbonate) ((m)PEG–PTMC) diblock and triblock copolymers for the formulation of in situ forming depot long-acting injectables by solvent exchange. The results shown in this manuscript demonstrate that it is possible to achieve long-term drug deliveries from suspension formulations prepared with these copolymers, with release durations up to several months in vitro. The utilization of copolymers with different PEG and PTMC molecular weights affords to modulate the release profile and duration. A pharmacokinetic study in rats with meloxicam confirmed the feasibility of achieving at least 28 days of sustained delivery by using this technology while showing good local tolerability in the subcutaneous environment. The characterization of the depots at the end of the in vivo study suggests that the rapid phase exchange upon administration and the surface erosion of the resulting depots are driving the delivery kinetics from suspension formulations. Due to the widely accepted utilization of meloxicam as an analgesic drug for animal care, the results shown in this article are of special interest for the development of veterinary products aiming at a very long-term sustained delivery of this therapeutic molecule.


Sign in / Sign up

Export Citation Format

Share Document